Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

53.87
Delayed Data
As of Mar 22
 +0.48 / +0.90%
Today’s Change
41.59
Today|||52-Week Range
56.50
+0.64%
Year-to-Date
Why Is Zoetis (ZTS) Up 3.1% Since the Last Earnings Report?
Mar 21 / Zacks.com - Paid Partner Content
Top Research Reports for March 9, 2017
Mar 09 / Zacks.com - Paid Partner Content
Here's How George Soros' Stock Portfolio Is Changing
Mar 14 / MotleyFool.com - Paid Partner Content
Trump's pledge on drug pricing squeezes pharma stocks
Mar 07 / FT.com - Paid Partner Content

Today’s Trading

Previous close53.39
Today’s open53.40
Day’s range53.24 - 53.95
Volume3,276,789
Average volume (3 months)3,353,157
Market cap$26.3B
Dividend yield0.78%
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+18.11%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)+2.58%
P/E ratio32.6
Price/Sales5.46
Price/Book17.70

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+1.38+1.16%
BAXBaxter International...+0.39+0.76%
INCYIncyte Corp+0.55+0.39%
MYLMylan NV+0.03+0.07%
Data as of 03/22/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.49
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts


Search for Jobs